Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.4M Sell
93,730
-1,112
-1% -$247K 2.05% 7
2025
Q4
$21.7M Buy
94,842
+492
+0.5% +$112K 2.21% 8
2025
Q3
$21.8M Buy
94,350
+5,606
+6% +$1.14M 2.32% 7
2025
Q2
$16.5M Sell
88,744
-984
-1% -$183K 1.9% 8
2025
Q1
$18.8M Sell
89,728
-3,726
-4% -$724K 2.28% 6
2024
Q4
$16.6M Buy
+93,454
New +$17.2M 1.96% 8
2024
Q2
$15.4M Buy
90,014
+1,322
+1% +$219K 2.04% 6
2024
Q1
$16.2M Sell
88,692
-649
-0.7% -$112K 2.16% 5
2023
Q4
$13.8M Buy
89,341
+1,233
+1% +$180K 1.95% 5
2023
Q3
$13.1M Sell
88,108
-1,304
-1% -$191K 2.05% 5
2023
Q2
$12M Buy
89,412
+454
+0.5% +$66.6K 1.76% 7
2023
Q1
$14.2M Buy
88,958
+526
+0.6% +$80.4K 2.23% 4
2022
Q4
$14.3M Buy
88,432
+533
+0.6% +$81.7K 2.33% 4
2022
Q3
$11.8M Buy
87,899
+552
+0.6% +$79.2K 2.06% 6
2022
Q2
$13.4M Sell
87,347
-2,278
-3% -$348K 2.19% 4
2022
Q1
$14.5M Sell
89,625
-282
-0.3% -$41K 2.05% 5
2021
Q4
$12.2M Buy
89,907
+4,846
+6% +$572K 1.56% 11
2021
Q3
$9.18M Buy
85,061
+3,491
+4% +$399K 1.29% 17
2021
Q2
$9.19M Sell
81,570
-1,110
-1% -$125K 1.31% 16
2021
Q1
$8.95M Sell
82,680
-128
-0.2% -$13.7K 1.36% 17
2020
Q4
$8.87M Sell
82,808
-905
-1% -$87K 1.44% 16
2020
Q3
$7.33M Sell
83,713
-2,241
-3% -$211K 1.37% 19
2020
Q2
$8.44M Sell
85,954
-424
-0.5% -$37.3K 1.65% 9
2020
Q1
$6.58M Sell
86,378
-1,560
-2% -$133K 1.64% 13
2019
Q4
$7.79M Buy
87,938
+982
+1% +$81.5K 1.56% 12
2019
Q3
$6.58M Sell
86,956
-4,586
-5% -$314K 1.42% 15
2019
Q2
$6.66M Sell
91,542
-1,199
-1% -$94.2K 1.48% 15
2019
Q1
$7.47M Buy
92,741
+46,871
+102% +$3.83M 1.73% 9
2018
Q4
$4.23M Sell
45,870
-476
-1% -$41.9K 1.74% 10
2018
Q3
$4.38M Sell
46,346
-208
-0.4% -$19.7K 1.57% 11
2018
Q2
$4.31M Sell
46,554
-742
-2% -$72.5K 1.62% 9
2018
Q1
$4.48M Sell
47,296
-3,165
-6% -$348K 1.67% 10
2017
Q4
$4.88M Sell
50,461
-2,348
-4% -$221K 1.75% 9
2017
Q3
$4.69M Sell
52,809
-1,410
-3% -$107K 1.73% 9
2017
Q2
$3.93M Sell
54,219
-714
-1% -$48K 1.52% 12
2017
Q1
$3.58M Buy
+54,933
New +$3.45M 1.36% 22

Other funds holding ABBV

Heritage Trust's ABBV Position: Q1 2026 in Review

Heritage Trust reduced its AbbVie (ABBV) stake by 1.2% in Q1 2026, selling an estimated $247K and leaving 93,730 shares worth $20.4M. The position accounts for 2.05% of the portfolio, ranked #7.

Heritage Trust first reported a position in ABBV in Q1 2017 and has held it in 36 quarters since. The position peaked at $21.8M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Heritage Trust held 93,730 shares of AbbVie worth $20.4M as of Q1 2026.
  • Heritage Trust sold 1,112 AbbVie shares in Q1 2026, an estimated $247K.
  • AbbVie made up 2.05% of Heritage Trust's portfolio in Q1 2026, its #7 holding.
  • Heritage Trust first reported a position in AbbVie in Q1 2017 and has held it in 36 quarters since.
  • Heritage Trust's AbbVie position peaked at $21.8M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Heritage Trust's 13F filing for Q1 2026, filed 13 May 2026.